(Q57911818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

primary progressive multiple sclerosis

1 January 2020

main subject

multiple sclerosis

0 references

0 references

magnetic resonance imaging

0 references

author

Jaume Sastre Garriga

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Nicola De Stefano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Xavier Montalban

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Alan J. Thompson

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Massimo Filippi

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

12

David H Miller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

11

Frederik Barkhof

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

9

Zhaleh Khaleeli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

4

Alex Rovira

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

13

Chris Polman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Marco Rovaris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Elda Judica

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Maria Pia Sormani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Beatrice Benedetti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Tijmen Korteweg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

21 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

455-464

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

MRI dynamics of brain and spinal cord in progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Primary and transitional progressive MS: a clinical and MRI cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

European Study on Intravenous Immunoglobulin in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Describing data requires no adjustment for multiple comparisons: a reply from Savitz and Olshan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Invited commentary: Re: "Multiple comparisons and related issues in the interpretation of epidemiologic data".

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Natural history of multiple sclerosis: a unifying concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Assessment and correction of B1-induced errors in magnetization transfer ratio measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Is inflammation important in early PPMS? a longitudinal MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Correlations between structural CNS damage and functional MRI changes in primary progressive MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

Evidence for widespread movement-associated functional MRI changes in patients with PPMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085129

21 January 2018

Identifiers

DOI

10.1177/1352458507085129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208869%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference